Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;15(3):444-456.
doi: 10.2174/1570159X14666161101092822.

Opioids Resistance in Chronic Pain Management

Luigi A Morrone  1   2 , Damiana Scuteri  1 , Laura Rombolà  1 , Hirokazu Mizoguchi  3 , Giacinto Bagetta  1   2
Affiliations
Review

Opioids Resistance in Chronic Pain Management

Luigi A Morrone et al. Curr Neuropharmacol. 2017 Apr.

Abstract

Chronic pain management represents a serious healthcare problem worldwide. Chronic pain affects approximately 20% of the adult European population and is more frequent in women and older people. Unfortunately, its management in the community remains generally unsatisfactory and rarely under the control of currently available analgesics. Opioids have been used as analgesics for a long history and are among the most used drugs; however, while there is no debate over their short term use for pain management, limited evidence supports their efficacy of long-term treatment for chronic non-cancer pain. Therapy with opioids is hampered by inter-individual variability and serious side effects and some opioids often result ineffective in the treatment of chronic pain and their use is controversial. Accordingly, for a better control of chronic pain a deeper knowledge of the molecular mechanisms underlying resistance to opiates is mandatory.

Keywords: Chronic pain; opiate resistance; polymorphisms.

PubMed Disclaimer

References

    1. Gupta S., Gupta M., Nath S., Hess G.M. Survey of European pain medicine practice. Pain Physician. 2012;15(6):E983–E994. [PMID: 23159983]. - PubMed
    1. Cherubino P., Sarzi-Puttini P., Zuccaro S.M., Labianca R. The management of chronic pain in important patient subgroups. Clin. Drug Investig. 2012;32(Suppl. 1):35–44. [http://dx.doi.org/10. 2165/11630060-000000000-00000]. - PubMed
    1. Pasternak G.W. Molecular insights into mu opioid pharmacology: From the clinic to the bench. Clin. J. Pain. 2010;26(Suppl. 10):S3–S9. [http://dx.doi.org/10.1097/AJP.0b013e3181c49d2e]. [PMID: 20026962]. - PMC - PubMed
    1. Pert C.B., Snyder S.H. Opiate receptor: demonstration in nervous tissue. Science. 1973;179(4077):1011–1014. [http://dx.doi.org/ 10.1126/science.179.4077.1011]. [PMID: 4687585]. - PubMed
    1. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975;258(5536):577–580. [http://dx.doi.org/10.1038/258577a0]. [PMID: 1207728]. - PubMed

Substances